Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1399 of 5804
-
New rad combo targets kidney cancer after immunotherapy fails
Disease control Recruiting nowThe objective of this single-center clinical study was to evaluate the disease control rate(DCR) and safety of multimodal radiotherapy in the treatment of patients with renal cell carcinoma (RCC) progressed after prior immunotherapy.
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 13:10 UTC
-
Could immune therapy ease nerve pain? new trial tests IVIG for small fiber neuropathy
Disease control Recruiting nowThis study will enroll patients with small fiber neuropathy (SFN). The study will look at an intravenous immunoglobulin (IVIG) called Panzyga. Panzyga is approved by the FDA as a therapy for Primary humoral immunodeficiency (PI) in patients 2 years of age and older; Chronic immun…
Phase: PHASE2 • Sponsor: Endeavor Health • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
ICU kidney trial aims to find best fluid removal rate
Disease control Recruiting nowIn Intensive Care Unit (ICU) patients with acute kidney injury (AKI) and treated with renal replacement therapy (RRT) often present a fluid overload which is associated with morbidity (mechanical ventilation duration increase, kidney recovery decrease) and mortality. Patients' p…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Magnetic gut device could revolutionize Weight-Loss surgery
Disease control CompletedThe objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a duodenal-ileal (D-I) anastomosis either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior …
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Smart radiation: MRI helps target head and neck cancer, spare healthy tissue
Disease control Recruiting nowThe purpose of the study is to determine if it is feasible to use magnetic resonance imaging (MRI) to adjust a portion of radiation therapy for patients with head and neck squamous cell carcinoma . The technique under study will be used to personalize the study treatment based on…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Diabetes drug could shield kidneys in rare disease
Disease control Recruiting nowThe primary objective of this study is to determine whether extended-release MF (in addition to standard of care (S-o-C)) is superior to placebo in reducing podocyte injury and promoting podocyte survival by 6-months in Focal Segmental Glomerulosclerosis (FSGS).
Phase: PHASE1, PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Vitamin d may shield bones from hormone therapy side effects
Disease control Recruiting nowThis phase III trial tests whether high-dose vitamin D works in treating androgen-deprivation therapy (ADT)-induced bone loss in patients with prostate cancer who are undergoing androgen-deprivation therapy. Vitamins are substances that the body needs to grow and develop normally…
Phase: PHASE3 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThe study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat tablets in the same doses.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can emotional brain waves wake the unresponsive?
Symptom relief CompletedThis is a randomized and controlled pilot study investigating the effects of intensive emotional stimulation with neurological waves (INES) on cognitive-motor functions in patients diagnosed with Vegetative State (VS) and Minimally Conscious State (MCS) following severe brain inj…
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a common Anti-Inflammatory replace opioids after hip surgery?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether the medication ketorolac can help manage pain after hip arthroscopy as well or better than the standard opioid-based pain medications. This study focuses on adult patients (over 18 years old) undergoing hip arthroscopy at Henry …
Phase: PHASE4 • Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a daily pastille help fight recurrent brain tumors?
Disease control Recruiting nowThe goal of this interventional study is to evaluate the efficacy of APG-157 in combination with Bevacizumab in subjects with recurrent high-grade glioma. The main questions the study aims to answer are: * Progression-free and overall survival of patients receiving this combinat…
Phase: PHASE1, PHASE2 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New mRNA flu vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to learn about the safety and effects of the study vaccine for the possible prevention of influenza. Influenza is a disease that can spread easily from one person to another and cause body aches, fever, cough, and other symptoms. The study vaccine is …
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
New drug may shield celiac patients from gluten damage
Disease control CompletedThe study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)
Phase: PHASE2 • Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New rapid blood test could slash unnecessary antibiotic use in sepsis
Disease control CompletedBacterial blood stream infections are common and life-threatening. Bloodstream infections have historically been identified using blood cultures, which often take 24-72 hours to result and are imperfectly sensitive. Early administration of antimicrobial therapy is a fundamental c…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New school program aims to stop depression in vulnerable teens
Prevention Recruiting nowDepression is a major public health concern. In Dutch adolescents, the prevalence of major depressive disorder is estimated at 3.8%, and one in five adolescents report depressive symptoms. Depression is a risk factor in adolescent suicide. School-based prevention programs, for ex…
Phase: NA • Sponsor: Ggz Oost Brabant • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Could probiotics stop ventilator pneumonia? new trial aims to find out
Prevention Recruiting nowPROACT study aims to resolve uncertainties to influence actual practice guidelines or public health policing regarding VAP prevention in ICU by using probiotics administration. Multi-trauma patients with a head injury OR stroke or brain haemorrhage patients without any sign of a…
Phase: NA • Sponsor: University of Bari • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Tiny implant could ease glaucoma pressure
Disease control OngoingThe VividWhite Glaucoma Implant (VW-51) is a novel surgical implant designed to treat glaucoma. This study is a 12-month, 65-participant non-comparative multicentre study to assess the safety and effectiveness of the VW-51 implant.
Phase: NA • Sponsor: VividWhite Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a daily shot slow PSP? new study tests long-term safety
Disease control CompletedThe study will be conducted by the Sponsor to evaluate Twelve-months Long-Term Safety and Efficacy of GV1001 (1.12 mg) administered subcutaneously as a treatment for Progressive Supranuclear Palsy(PSP). In 75 patients diagnosed with PSP Richardson(PSP-RS) or PSP-Parkinsonism (PSP…
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Spit test could spot concussions in athletes
Diagnosis Recruiting nowConcussion (CC) (also called mild head trauma), which accounts for 85% of all head injuries, is very common in professional and amateur athletes. CC is an injury to the brain resulting from the direct or indirect impact of external mechanical forces, momentarily disrupting its fu…
Sponsor: Sys2Diag • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Can a Tight-Control strategy tame lupus?
Disease control Recruiting nowMulticenter, national, two-armed cluster-randomized controlled trial to evaluate the effect of a treat-to-target (T2T) strategy in in systemic lupus erythematosus (SLE). 14 centers will be randomized 1:1 to T2T or standard of care. Per arm 303 patients with SLE who are not in rem…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC